Across TCGA pan-cancer cohorts, LINC00477 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated LINC00477 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC00477 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00477 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

CESC, UCEC, and LGG are the cancer types where LINC00477 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	All	0.532	0.800	.027	6	view →
UCEC	DFS	Median	II,III,IV	1.000	0.311	.040	4	view →
LGG	DFS	Median	All	0.110	0.826	<.001	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: LINC00477 tumor-vs-normal RNA expression · all LINC00477 data types